X Bioscience PCL (BKK:XBIO) Inventories, Raw Materials & Components: ฿0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is X Bioscience PCL Inventories, Raw Materials & Components?

X Bioscience PCL BKK:XBIO Inventories, Raw Materials & Components is ฿0.0 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

X Bioscience PCL's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ฿0.0 Mil.

X Bioscience PCL's quarterly raw materials increased from Sep. 2025 (฿0.0 Mil) to Dec. 2025 (฿2.1 Mil) but then declined from Dec. 2025 (฿2.1 Mil) to Mar. 2026 (฿0.0 Mil).

X Bioscience PCL's annual raw materials increased from Dec. 2023 (฿4.9 Mil) to Dec. 2024 (฿7.3 Mil) but then declined from Dec. 2024 (฿7.3 Mil) to Dec. 2025 (฿2.1 Mil).

X Bioscience PCL Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for X Bioscience PCL's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

X Bioscience PCL Inventories, Raw Materials & Components Chart

X Bioscience PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.76 6.95 4.92 7.28 2.15

X Bioscience PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 2.15 0.00

X Bioscience PCL Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ฿0.0 Mil mean?
X Bioscience PCL (BKK:XBIO) has a Inventories, Raw Materials & Components of ฿0.0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on X Bioscience PCL and its competitors.
Is X Bioscience PCL's Inventories, Raw Materials & Components too high?
X Bioscience PCL's current Inventories, Raw Materials & Components is ฿0.0 Mil.
How does X Bioscience PCL's Inventories, Raw Materials & Components compare to SYY and USFD?
X Bioscience PCL's Inventories, Raw Materials & Components of ฿0.0 Mil can be compared against companies in the Restaurants industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Restaurants company?
A good Inventories, Raw Materials & Components depends on the Restaurants industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on X Bioscience PCL and its competitors. X Bioscience PCL's current Inventories, Raw Materials & Components is ฿0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, X Bioscience PCL (BKK:XBIO) is currently considered Possible Value Trap. The stock's GF Value™ is ฿0.10, compared to a current price of ฿0.07 — trading 30% below its estimated fair value. The current Inventories, Raw Materials & Components is ฿0.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For X Bioscience PCL (BKK:XBIO), the current Inventories, Raw Materials & Components is ฿0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

X Bioscience PCL Business Description

Other Exchanges XBIO-W7:Thailand
Address Phaholyothin Road, No. 304, Vanit Place Aree Tower, Tower A, Units 1803-1806, 18th Floor, Samsennai, Phayathai District, Bangkok, THA, 10400
X Bioscience PCL, along with its subsidiaries, is mainly engaged in selling food and beverages by operating restaurants and bakery shops under the Le Boeuf, Kagonoya, Bake Cheese Tart, Croquant Chou ZakuZaku, and RAPL trademarks. Additionally, the Group is involved in the production and distribution of biological products. It operates in two business segments: the food and beverage sales segment, which generates maximum revenue, and the production and distribution of biological products segment. Geographically, the Group operates only in Thailand.